Home |Japanese | Apply Now | Editor FAQ | About | Nyaya Health | ProEdit Japan

About EquityEdit: Management

Board of Directors
Brian Taylor Slingsby, MPH, PhD. Founding Board Member. Dr. Slingsby is a public health specialist and medical editor. He is one of the founders of EquityEdit and serves as a liaison between EquityEdit and ProEdit Japan. He is also a Freeman Research Fellow at the University of Hawaii, a Visiting Research Fellow at the University of Tokyo and an Adjunct Assistant Professor at Kyoto University.  His research and teaching activities focus on models of clinical decision-making and healthcare infrastructure in the US and Japan.  Dr. Slingsby has been published in journals including Academic Medicine, American Journal of Bioethics, Journal of General Internal Medicine, Social Science and Medicine and the Lancet.  Pubmed references.

Duncan Smith-Rohrberg Maru, MPhil. Founding Board Member. Mr. Maru is an MD/PhD candidate at Yale University and Chief Executive Officer of Nyaya Health. He has experience handling document editing for medical researchers in Japan and India. He is a public health researcher who has published widely on aspects of social medicine, substance abuse, HIV, and tuberculosis in journals such as Nature and JAIDS, the Lancet Infectious Diseases, PLoS Medicine, and Clinical Infectious DiseasesPubmed references.

Christopher Belknap
. Board Member. Mr. Belknap is a 4th year undergraduate at Yale University. He has helped design websites and editor application systems for EquityEdit, and represented the organization at the third annual Global Knowledge Conference in Malaysia. Mr. Belknap has done health economics research in Nepal with Nyaya Health, and public health research at The Johns Hopkins Hospital. He also has experience in scientific writing and editing with PH The Yale Journal of Public Health.

Sanjay Basu, MSc. Board Member. Mr. Basu is an MD/PhD candidate at Yale University and Chief Operating Officer of Nyaya Health.  He is involved in strategic planning for EquityEdit and helps to identify innovative public health organizations to serve as beneficiaries. Additionally, he consults as a program manager for Oxfam UK, and has maintained budgets and grants for two non-profit organizations. His PhD work is on developing mathematical models of infectious disease transmission.  He was an editor for the Yale Journal of Health Policy, Law & Ethics and The MIT Research Journal, and has published in journals including Science, Nature, PLoS Medicine, and the Lancet.   Pubmed references.

Ellen Tarr, PhD.  Board Member.  Dr. Tarr is a postdoctoral researcher at the University of Kansas and a senior editor for EquityEdit. As part of the IRACDA post-doctoral program at KU, she taught for three years at Haskell Indian Nations University, a minority-serving institution with an exclusively Native American enrollment. Her current research interests are comparative immunology and host-pathogen interactions, specifically immune defense mechanisms in nematodes and parasitic nematode infections. Her previous work has been published in Molecular and Biochemical Parasitology, Trends in Parasitology, and GenePubmed references.

Management Structure
To maximize revenue to participating non-profit beneficiaries, the management team of EquityEdit remains all-volunteer. Since these volunteers are unpaid, other incentives exist to create a sustainable management structure. The primary incentive is their desire to fundraise for the nonprofit beneficiary. To facilitate this, a major criteria for an EquityEdit beneficiary (in addition to being small, innovative, pro-poor) is that they have at least one executive or board member who is qualified and interested in improving EquityEdit. This is a key aspect of developing a sustainable model that doesn't require a paid executive director, since the beneficiary executive would be significantly invested in the financial success of EquityEdit. Once a non-profit joins, the goal would be to quickly expand to and sustain annual revenue streams for the non-profit. This revenue would continue for at least five years, during which time the point-person at the non-profit would be expected to engage in improving EquityEdit.


Board of Directors

Brian Taylor Slingsby, MPH, Ph.D., ProEdit Japan, Inc. and George Washington University School of Medicine and Health Sciences, Co-Founder

Duncan Smith-Rohrberg Maru, Nyaya Health and Yale University School of Medicine, Co-Founder

Christopher Belknap, Nyaya Health and Yale University

Sanjay Basu, Nyaya Health and Yale University School of Medicine

Ellen Tarr, University of Kansas


Board of Advisors

David Berg, Ph.D., Psychologist, Yale University School of Medicine

Matt Cockerill, Ph.D., Publisher, Biomed Central

Emma Hitt, Ph.D., Biomedical Editor, Hitt Medical Writing

John McConnell, Editor, Lancet Infectious Diseases

George Stefano,  Ph.D.,  Editor-in-Chief, Medical Science Monitor

Gavin Yamey, Senior Editor, PLoS Medicine

Improving Biomedical Writing, Funding Biomedical Equity